16
Dec

Cyclacel Pharmaceuticals’ in-development leukemia drug has little chance of meeting its primary goal in a late-stage study, independent advisers said. But, because the treatment isn’t leading to serious side effects, the company is keeping the trial running.

…read more

Source: Cyclacel’s cancer drug isn’t working in Phase III, but that won’t stop the trial

    

0 No comments